CuroTis

VASCULAR THERAPIES

This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.

Artifex

This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.

Silk Biomaterials

This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.

BioTube, Inc.

BioTube developing subcutaneous tissue-engineering moulds for creating autologous vascular grafts for patients requiring bypass surgery or regenerative medicine treatments.

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.

Tengion Inc

This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.

VenoStent

This company develops bioabsorbable vascular wraps for chronic kidney disease patients to improve the durability and success of haemodialysis access sites.

Kuros Biosciences

This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.